The prevalence of melanocytic naevi among schoolchildren in South Hungary

Journal of the European Academy of Dermatology and Venereology

Volumn 22, Issue 12, 2008, Pages 1412-1422

  Csoma, Z ^a   Erdei, Z ^a   Bartusek, D ^a   Dosa Racz, E ^a   Dobozy, A ^a   Kemeny, L ^a   Olah, J ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Health educational programme; Malignant melanoma; Melanocytic naevi; Pigmentary trait; Sun exposure

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; EYE COLOR; FAMILY HISTORY; FEMALE; GENDER; HAIR COLOR; HUMAN; HUNGARY; MAJOR CLINICAL STUDY; MALE; MELANOCYTIC NEVUS; PHENOTYPE; PIGMENTATION; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SCHOOL CHILD; SKIN EXAMINATION; SUN EXPOSURE; SUNBURN;

ADOLESCENT; CROSS-SECTIONAL STUDIES; EYE COLOR; FEMALE; HAIR COLOR; HUMANS; HUNGARY; MALE; NEVUS, PIGMENTED; PHENOTYPE; PREVALENCE; QUESTIONNAIRES; SEX FACTORS; SUNLIGHT;

EID: 56549083968     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2008.02887.x     Document Type: Article

References (59)

1. de Vries E, Coebergh JW. Cutaneous malignant melanoma in Europe. Eur J Cancer 2004 40 : 2355 2366.
2. Marks R. Epidemiology of melanoma. Clin Exp Dermatol 2000 25 : 459 463.
3. Garbe C, Buttner P, Weiss J et al. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 1994 102 : 695 699.
4. MacKie RM. Incidence, risk factors and prevention of melanoma. Eur J Cancer 1998 34 (Suppl. 3 S3 S6 S3 S6.
5. Rigel DS, Carucci JA. Malignant melanoma: prevention, early detection, and treatment in the 21st century. CA Cancer J Clin 2000 50 : 215 236.
6. Bastuji-Garin S, Diepgen TL. Cutaneous malignant melanoma, sun exposure, and sunscreen use: epidemiological evidence. Br J Dermatol 2002 146 (Suppl. 61 24 30.
7. Herd RM, Cooper EJ, Hunter JA et al. Cutaneous malignant melanoma. Publicity, screening clinics and survival - the Edinburgh experience 1982-90. Br J Dermatol 1995 132 : 563 570.
8. Gaudi I, Kásler M. A rosszindulatú daganatos halálozás változása 1975 és 2001 között Magyarországon. Magy Onkol 2002 46 : 291 295.
9. Gaudi I, Kásler M. Melanomás megbetegedések a Nemzeti Rákregiszter alapján. Magy Onkol 2003 47 : 13 17.
10. Ottó S, Kásler M. A hazai és nemzetközi daganatos halálozási és megbetegedési mutatók alakulása. A népegészségügyi programok jellegzetességei és várható eredményei. Magy Onkol 2005 49 : 99 107.
11. Ottó S, Kásler M. Rákmortalitás és -incidencia hazánkban, az európai adatok tükrében. Magy Onkol 2002 46 : 111 117.
12. Kopf AW, Kripke ML, Stern RS. Sun and malignant melanoma. J Am Acad Dermatol 1984 11 : 674 684.
13. Rodenas JM, Delgado-Rodriguez M, Herranz MT, Tercedor J, Serrano S. Sun exposure, pigmentary traits, and risk of cutaneous malignant melanoma: a case-control study in a Mediterranean population. Cancer Causes Control 1996 7 : 275 283.
14. Cho E, Rosner BA, Feskanich D, Colditz GA. Risk factors and individual probabilities of melanoma for whites. J Clin Oncol 2005 23 : 2669 2675.
15. Naldi L, Altieri A, Imberti GL et al. Sun exposure, phenotypic characteristics, and cutaneous malignant melanoma. An analysis according to different clinico-pathological variants and anatomic locations (Italy). Cancer Causes Control 2005 16 : 893 899.
16. Garbe C, Kruger S, Stadler R, Guggenmoos-Holzmann I, Orfanos CE. Markers and relative risk in a German population for developing malignant melanoma. Int J Dermatol 1989 28 : 517 523.
17. MacKie RM, Aitchison T. Severe sunburn and subsequent risk of primary cutaneous malignant melanoma in scotland. Br J Cancer 1982 46 : 955 960.
18. Green A, Siskind V, Bain C, Alexander J. Sunburn and malignant melanoma. Br J Cancer 1985 51 : 393 397.
19. Dubin N, Moseson M, Pasternack BS. Epidemiology of malignant melanoma: pigmentary traits, ultraviolet radiation, and the identification of high-risk populations. Recent Results Cancer Res 1986 102 : 56 75.
20. Green A, Bain C, McLennan R, Siskind V. Risk factors for cutaneous melanoma in Queensland. Recent Results Cancer Res 1986 102 : 76 97.
21. Evans RD, Kopf AW, Lew RA et al. Risk factors for the development of malignant melanoma - I: Review of case-control studies. J Dermatol Surg Oncol 1988 14 : 393 408.
22. Carli P, Biggeri A, Giannotti B. Malignant melanoma in Italy: risks associated with common and clinically atypical melanocytic nevi. J Am Acad Dermatol 1995 32 : 734 739.
23. Fargnoli MC, Piccolo D, Altobelli E, Formicone F, Chimenti S, Peris K. Constitutional and environmental risk factors for cutaneous melanoma in an Italian population. A case-control study. Melanoma Res 2004 14 : 151 157.
24. Kraemer KH, Greene MH, Tarone R, Elder DE, Clark WH Jr., Guerry D 4th. Dysplastic naevi and cutaneous melanoma risk. Lancet 1983 2 : 1076 1077.
25. Kruger S, Garbe C, Buttner P, Stadler R, Guggenmoos-Holzmann I, Orfanos CE. Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects. J Am Acad Dermatol 1992 26 : 920 926.
26. Garbe C, Buttner P, Weiss J et al. Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 1994 102 : 700 705.
27. Halpern AC, Guerry D, Elder DE et al. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study. Arch Dermatol 1991 127 : 995 999.
28. Kanzler MH, Mraz-Gernhard S. Primary cutaneous malignant melanoma and its precursor lesions: diagnostic and therapeutic overview. J Am Acad Dermatol 2001 45 : 260 276.
29. Garbe C, Eigentler TK. Diagnosis and treatment of cutaneous melanoma: state of the art 2006. Melanoma Res 2007 17 : 117 127.
30. Dennis LK, White E, Lee JA et al. Constitutional factors and sun exposure in relation to nevi: a population-based cross-sectional study. Am J Epidemiol 1996 143 : 248 256.
31. Kelly JW, Rivers JK, MacLennan R, Harrison S, Lewis AE, Tate BJ. Sunlight: a major factor associated with the development of melanocytic nevi in Australian schoolchildren. J Am Acad Dermatol 1994 30 : 40 48.
32. Fritschi L, McHenry P, Green A, Mackie R, Green L, Siskind V. Naevi in schoolchildren in Scotland and Australia. Br J Dermatol 1994 130 : 599 603.
33. Carli P, Biggeri A, Nardini P, De Giorgi V, Giannotti B. Sun exposure and large numbers of common and atypical melanocytic naevi: an analytical study in a southern European population. Br J Dermatol 1998 138 : 422 425.
34. Darlington S, Siskind V, Green L, Green A. Longitudinal study of melanocytic nevi in adolescents. J Am Acad Dermatol 2002 46 : 715 722.
35. Gallagher RP, McLean DI, Yang CP et al. Suntan, sunburn, and pigmentation factors and the frequency of acquired melanocytic nevi in children. Similarities to melanoma: the Vancouver Mole Study. Arch Dermatol 1990 126 : 770 776.
36. Carli P, Biggeri A, Nardini P, Salani B, Giannotti B. Epidemiology of atypical melanocytic naevi: an analytical study in a Mediterranean population. Eur J Cancer Prev 1997 6 : 506 511.
37. Carli P, Naldi L, Lovati S, La Vecchia C. The density of melanocytic nevi correlates with constitutional variables and history of sunburns: a prevalence study among Italian schoolchildren. Int J Cancer 2002 101 : 375 379.
38. Dulon M, Weichenthal M, Blettner M et al. Sun exposure and number of nevi in 5- to 6-year-old European children. J Clin Epidemiol 2002 55 : 1075 1081.
39. Green A, Siskind V, Hansen ME, Hanson L, Leech P. Melanocytic nevi in schoolchildren in Queensland. J Am Acad Dermatol 1989 20 : 1054 1060.
40. English DR, MacLennan R, Rivers JK, Kelly J, Armstrong BK. Epidemiological studies of melanocytic nevi: protocol for identifying and recording nevi. Internal Report 90/002. International Agency for Research on Cancer, Lyon, France, 1990.
41. Rivers JK, MacLennan R, Kelly JW et al. The eastern Australian childhood nevus study: prevalence of atypical nevi, congenital nevus-like nevi, and other pigmented lesions. J Am Acad Dermatol 1995 32 : 957 963.
42. Valiukeviciene S, Miseviciene I, Gollnick H. The prevalence of common acquired melanocytic nevi and the relationship with skin type characteristics and sun exposure among children in Lithuania. Arch Dermatol 2005 141 : 579 586.
43. Ballone E, Passamonti M, Lappa G, Di Plasio G, Fazii P. Pigmentary traits, nevi and skin phototypes in a youth population of Central Italy. Eur J Epidemiol 1999 15 : 189 195.
44. Rao BK, Wang SQ, Murphy FP. Typical dermoscopic patterns of benign melanocytic nevi. Dermatol Clin 2001 19 : 269 284.
45. Kallas M, Rosdahl I, Fredriksson M, Synnerstad I. Frequency and distribution pattern of melanocytic naevi in Estonian children and the influence of atopic dermatitis. J Eur Acad Dermatol Venereol 2006 20 : 143 148.
46. Synnerstad I, Nilsson L, Fredrikson M, Rosdahl I. Frequency and distribution pattern of melanocytic naevi in Swedish 8-9-year-old children. Acta Derm Venereol 2004 84 : 271 276.
47. Sigg C, Pelloni F, Schnyder UW. Frequency of congenital nevi, nevi spili and cafe-au-lait spots and their relation to nevus count and skin complexion in 939 children. Dermatologica 1990 180 : 118 123.
48. Augustsson A, Stierner U, Suurkula M, Rosdahl I. Prevalence of common and dysplastic naevi in a Swedish population. Br J Dermatol 1991 124 : 152 156.
49. Pope DJ, Sorahan T, Marsden JR, Ball PM, Grimley RP, Peck IM. Benign pigmented nevi in children. Prevalence and associated factors: the West Midlands, United Kingdom Mole Study. Arch Dermatol 1992 128 : 1201 1206.
50. Luther H, Altmeyer P, Garbe C et al. Increase of melanocytic nevus counts in children during 5 years of follow-up and analysis of associated factors. Arch Dermatol 1996 132 : 1473 1478.
51. Karlsson P, Stenberg B, Rosdahl I. Prevalence of pigmented naevi in a Swedish population living close to the Arctic Circle. Acta Derm Venereol 2000 80 : 335 339.
52. English DR, Armstrong BK. Melanocytic nevi in children. I. Anatomic sites and demographic and host factors. Am J Epidemiol 1994 139 : 390 401.
53. Rampen FH, Fleuren BA, de Boo TM, Lemmens WA. Unreliability of self-reported burning tendency and tanning ability. Arch Dermatol 1988 124 : 885 888.
54. English JS, Swerdlow AJ, MacKie RM et al. Relation between phenotype and banal melanocytic naevi. Br Med J (Clin Res Ed) 1987 294 : 152 154.
55. Armstrong BK, de Klerk NH, Holman CD. Etiology of common acquired melanocytic nevi: constitutional variables, sun exposure, and diet. J Natl Cancer Inst 1986 77 : 329 335.
56. Breitbart M, Garbe C, Buttner P et al. Ultraviolet light exposure, pigmentary traits and the development of melanocytic naevi and cutaneous melanoma. A case-control study of the German Central Malignant Melanoma Registry. Acta Derm Venereol 1997 77 : 374 378.
57. Bauer J, Buttner P, Wiecker TS et al. Interventional study in 1232 young German children to prevent the development of melanocytic nevi failed to change sun exposure and sun protective behavior. Int J Cancer 2005 116 : 755 761.
58. Autier P, Dore JF, Cattaruzza MS et al. Sunscreen use, wearing clothes, and number of nevi in 6- to 7-year-old European children. European Organization for Research and Treatment of Cancer Melanoma Cooperative Group. J Natl Cancer Inst 1998 90 : 1873 1880.
59. Gallagher RP, Rivers JK, Lee TK et al. Broad-spectrum sunscreen use and the development of new nevi in white children. JAMA 2000 283 : 2955 2960.